By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioSeek has received $696,000 in funding from the US Environmental Protection Agency to continue providing cell-based assay screening support for the EPA ToxCast screening program, the Asterand subsidiary said today.

BioSeek said that under the phase II funding it will continue to use its BioMap Systems platform, which combines human cell-based assay data with clinically relevant results, to study compounds for their potential toxicity and effects on human health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.